CareLit Fachartikel

Impact assessment of [18F]FDG PET/CT in predicting EGFR gene mutation status in patients with lung adenocarcinoma using recovery coefficient-based correction of semi-quantitative…

Aleksei Leontev, Angelina Lokhova, Aleksandr Khalimon, Malika Khodzhibekova, Tatyana Lazutina, Gulnara Khamadeeva, Daria Khodakova, Irina Pylova, Vitaly Bobrov, Leila Atakishieva, Natalia Kadymova, Anastasia Nikiforuk, Bogdan Shvets, Nadezhda Volchenko, Vikto… · Nuklearmedizin - NuclearMedicine · 2026 · Heft 03 · S. 199-206

Dokument
979660
CareLit-ID
Jahr
2026
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Nuklearmedizin - NuclearMedicine
Autor:innen
Aleksei Leontev, Angelina Lokhova, Aleksandr Khalimon, Malika Khodzhibekova, Tatyana Lazutina, Gulnara Khamadeeva, Daria Khodakova, Irina Pylova, Vitaly Bobrov, Leila Atakishieva, Natalia Kadymova, Anastasia Nikiforuk, Bogdan Shvets, Nadezhda Volchenko, Vikto…
Ausgabe
Heft 03 / 2026
Jahrgang 65
Seiten
199-206
Erschienen: 2026-06-01 00:00:00
ISSN
0029-5566

Zusammenfassung

Abstract Aim The aim of this study was to assess the impact of [18F]FDG PET/CT in predicting EGFR gene mutation status in patients with lung adenocarcinoma using recovery coefficient-based (RC-based) correction of semi-quantitative and volume-based PET metrics. Methods A retrospective multi-center study included 63 patients diagnosed with lung adenocarcinoma who underwent [18F]FDG PET/CT. Acquisition was performed according to the EANM guidelines using two EARL-accredited PET/CT-systems. All patients were divided into an EGFR-mutant (n=30) and a wild-type (n=33) groups based on the results of molecular testing.…

Schlagworte

lung adenocarcinoma epidermal growth factor receptor PET/CT [18F]FDG recovery coefficient SUV harmonization Nuklearmedizin - NuclearMedicine